Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial

pharmatimesAugust 05, 2020

Tag: Novartis , CAR-T therapy , Kymriah

PharmaSources Customer Service